CER board seeks public input
Posted on July 21, 2011 | No Comments
PDF Version
Details
Library
Key Developments
Implementation Briefs
A new Comparative Effectiveness Research (CER) Board, established by the Affordable Care Act (ACA), is seeking public input as to what kinds of research should be performed. The ACA helped establish the Patient-Centered Outcomes Research Institute (PCORI), which will provide information to consumers to help guide their treatment decisions. PCORI is an independent body, charged with overseeing CER guidelines in the U.S.
For more information on CER, click here.
May 4, 2012
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors recently amended its January 2012 draft research agenda in response to public comments. The board found 15 major themes that emerged from 474 public comments. The purpose of the National Priorities for Research and Research Agenda is to guide funding for comparative clinical effectiveness research. The agenda amendments address PCORI's focus on patient engagement and transparency, patients with multiple chronic conditions, patients with rare diseases, improvement of health delivery systems, and health literacy.
The final version of the agenda and the national research priorities...
January 24, 2012
The Patient-Centered Outcomes Research Institute (PCORI) proposed national priorities for patient-centered comparative clinical effectiveness in their first version of PCORI’s Research Agenda. PCORI expects to learn and update this as
we move forward. We are not specifying or prioritizing any particular condition or disease for
research, although we may do so in the future. Consistent with the criteria outlined in the Affordable Care Act (ACA), PCORI’s first research agenda looks at:
-Comparisons of Prevention, Diagnosis, and Treatment Options...
October 19, 2011
In the Health Affairs article, "How Medicare Could Use Comparative Effectiveness Research In Deciding On New Coverage And Reimbursement," the authors call for research regarding ways to control escalating Medicare costs, while maintaining access to beneficial services. The article proposes a payment model that would incorporate comparative effectiveness research into the Medicare reimbursement model. The authors suggest that Medicare pay equally for services that yield comparable benefits and appropriate higher payment for services with benefits proven to exceed those derived from alternative options. New services without such evidence would receive usual reimbursement rates until enough evidence mounted to justify reevaluation. Although difficult to modify Medicare reimbursement, especially in such partisan political times, the authors urge government to employ comparative effectiveness research in service rewards, improve incentives for cost-effective innovation, and place Medicare on a more stable fiscal footing.
July 27, 2011
The U.S. Department of Health and Human Services (HHS) has issued an Advance Notice of Proposed Rulemaking (ANPRM) soliciting comments on how regulations governing human subject research might be modernized, including making changes to the Common Rule. These regulations have not been have not kept pace with advances in science and human subject research, so updates would be welcome and will apply to all human subject research funded by Affordable Care Act (ACA).
May 7, 2010
The Department of Health and Human Services announced May 6 that it has awarded six million dollars under the American Recovery and Reinvestment Act of 2009 to Mathematica Policy Research, Inc. to establish a Center of Excellence in Research on Disability Services, Care Coordination, and Integration.
http://www.hhs.gov/news/press/2010pres/05/20100506a.html.
July 1, 2010
The recently enacted Patient Protection and Affordable Care Act (PPACA) builds on federal efforts to support and direct research comparing patient treatments.





No Comments